Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07180108Phase 1Recruiting
Phase 1, randomised, open-label trial of psilocybin (5 arms), sponsored by Johns Hopkins University. Primary endpoints: Challenging Experiences Questionnaire, Psychological Insight Questionnaire and 15 more. Started Aug 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07180108.